Zaleplon, A Novel Nonbenzodiazepine Hypnotic, Effectively Treats Insomnia in Elderly Patients Without Causing Rebound Effects
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Insomnia is a very common symptom, particularly in the elderly. Thus, all hypnotic medications should be carefully evaluated in the elderly population. Zaleplon, a new nonbenzodiazepine hypnotic with a short elimination half-life (approximately 1 hour), was evaluated in the current study. METHOD: This multicenter, randomized, placebo-controlled outpatient study evaluated the efficacy and safety of zaleplon, 5 and 10 mg, in elderly patients with insomnia (as defined by DSM-IV); zolpidem, 5 mg, was the active comparator. Sleep was assessed in 549 elderly patients (>/= 65 years old) by using morning questionnaires completed after each of 7 baseline nights during which placebo was given, 14 nights of double-blind treatment, and 7 nights of placebo after discontinuation of active treatment. RESULTS: Zaleplon, 10 mg, and zolpidem, 5 mg, significantly reduced sleep latency during both weeks of the study. Zaleplon, 5 mg, reduced sleep latency only during week 2. Sleep duration was increased with zolpidem, 5 mg, during weeks 1 and 2 and with zaleplon, 10 mg, during week 1. No clinically significant rebound insomnia was observed after discontinuation of treatment with zaleplon, whereas evidence of rebound effects was seen with zolpidem. There was no significant difference between either zaleplon dose and placebo in the frequency of any central nervous system adverse events. CONCLUSION: Zaleplon is effective in reducing latency to sleep without evidence of undesired effects in elderly patients with insomnia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A self-rating depression scale
ZUNG, W. W. K. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01720310065008 · Cited by 9,813
A Rating Instrument For Anxiety Disorders
Zung, W. W. K. (1971) · Psychosomatics · doi:10.1016/s0033-3182(71)71479-0 · Cited by 4,578
Sleep Complaints Among Elderly Persons: An Epidemiologic Study of Three Communities
Foley, D. J., Monjan, A. A., Brown, S. L., Simonsick, E. M., Wallace, R. B., & Blazer, D. G. (1995) · Sleep · doi:10.1093/sleep/18.6.425 · Cited by 1,610
Insomnia and Its Treatment: Prevalence and Correlates
Mellinger, G. D. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790260019002 · Cited by 1,071
Cited by
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
Avidan, A. Y., Fries, B. E., James, M. L., Szafara, K. L., Wright, G. T., & Chervin, R. D. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53304.x · Cited by 343
Zolpidem: A Review of Its Use in the Management of Insomnia
Swainston Harrison, T., & Keating, G. M. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00008 · Cited by 323
Insomnia in the Elderly: Cause, Approach, and Treatment
Kamel, N. S., & Gammack, J. K. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.10.051 · Cited by 307
Zaleplon: A Review of its Use in the Treatment of Insomnia
Dooley, M., & Plosker, G. L. (2000) · Drugs · doi:10.2165/00003495-200060020-00014 · Cited by 287
LEMOINE, P., NIR, T., LAUDON, M., & ZISAPEL, N. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00613.x · Cited by 261
The assessment and management of insomnia: an update
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019) · World Psychiatry · doi:10.1002/wps.20674 · Cited by 256
Long-term use of sedative hypnotics in older patients with insomnia
Ancoli-Israel, S., Richardson, G. S., Mangano, R. M., Jenkins, L., Hall, P., & Jones, W. S. (2005) · Sleep Medicine · doi:10.1016/j.sleep.2004.10.015 · Cited by 154
Self-citationComparative Tolerability of Newer Agents for Insomnia
Zammit, G. (2009) · Drug Safety · doi:10.2165/11312920-000000000-00000 · Cited by 98
Hypnotics in Insomnia: The Experience of Zolpidem
MacFarlane, J., Morin, C. M., & Montplaisir, J. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.017 · Cited by 94
IS THERE A RATIONALE FOR PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY? REVIEW OF THE LITERATURE
Petrovic, M., Mariman, A., Warie, H., Afschrift, M., & Pevernagie, D. (2003) · Acta Clinica Belgica · doi:10.1179/acb.2003.58.1.004 · Cited by 76
“Prevalence rates of anxiety differ between studies and age ranges under observation (35, 50).”
BackgroundWatson, N. F., Benca, R. M., Krystal, A. D., McCall, W. V., & Neubauer, D. N. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072493 · Cited by 59
“Both doses of zolpidem were associated with higher rates of rebound insomnia for sleep latency and TST on night 1, whereas zaleplon discontinuation was free of rebound insomnia [60].”
BackgroundBenefit-Risk Assessment of Zaleplon in the Treatment of Insomnia
Barbera, J., & Shapiro, C. (2005) · Drug Safety · doi:10.2165/00002018-200528040-00003 · Cited by 51
Feinsilver, S. H., & Hernandez, A. B. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.06.009 · Cited by 44
Huang, M. P., Radadia, K., Macone, B. W., Auerbach, S. H., & Datta, S. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.018 · Cited by 39
“ike these animal studies, studies in human subjects have shown hat zolpidem, in doses between 5 and 20 mg, shortens the latency o non-REM sleep and also increases the total amount of nonEM sleep [1,88,107].”
Result
Metadata
- Authors
- Ancoli-Israel, S., Walsh, J. K., Mangano, R. M., & Fujimori, M.
- Venue
- The Primary Care Companion For CNS Disorders
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 1999-08-01
- Volume
- 1
- Issue
- 4
- Pages
- 114-120
- ISSN
- 2155-7772 (ISSN-L)
- 2155-7780
- OpenAlex
- W2037926687
- Cited by
- 140
- References
- 4
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.